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Objective: The aim of the study was to examine the relationship between perceived treatment 
adherence and health-related quality of life (HRQOL) in children with arthritis, from both par-
ent and child perspectives.
Methods: Patients and their parents, who attended the juvenile idiopathic arthritis (JIA) clinic 
at the Montreal Children's Hospital, completed the Juvenile Arthritis Quality of Life Question-
naire (JAQQ), and either the Child Adherence Report Questionnaire (CARQ) or the Parent 
Adherence Report Questionnaire (PARQ). Linear regression models examined the associations 
between perceived treatment adherence and HRQOL while adjusting for age, severity, duration 
of the disease, and complexity of the medical regimen.
Results: Perceived adherence to medications was associated with a better HRQOL total score 
from the children’s perspective (β = −0.02, 95% conﬁ  dence interval [CI] = −0.03, −0.004), 
particularly with respect to gross motor (β = −0.03, 95% CI = −0.05, −0.01) and psychosocial 
functions (β = −0.03, 95% CI = −0.04, −0.01). According to parents, perceived adherence to 
exercises was associated with fewer symptoms (β = −0.01, 95% CI = −0.03, 0.000) and better 
psychosocial functioning (β = −0.01, 95% CI = −0.03, −0.002).
Conclusion: Perceived adherence to medications is associated with an improved HRQOL 
according to children. According to parents, adherence to exercises may be associated with an 
improved HRQOL.
Keywords: treatment adherence, juvenile idiopathic arthritis, health-related quality of life
Introduction
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in childhood 
and a leading cause of childhood disability (Woo and Wedderburn 1998; Petty et al 2004; 
Petty and Cassidy 2005). The management of JIA requires a multi-disciplinary treat-
ment approach often involving several types of nonsteroidal antiinﬂ  ammatory drugs 
(NSAIDs), corticosteroids, and/or disease-modifying antirheumatic drugs (DMARDs) 
such as methotrexate or tumor necrosis factor-α inhibitors (TNFα-inhibitors) together 
with an exercise program that might include the application of a physical therapy 
regimen and the wearing of splints (Petty and Cassidy 2005).
An important outcome often used in JIA is health-related quality of life (HRQOL). 
In general, HRQOL is deﬁ  ned as “a multidimensional functional effect of an illness or 
a medical condition and its consequence upon the child or adolescent as perceived by 
the child, adolescent and family” (Ronen et al 2001). It has often been used to evalu-
ate the effectiveness of treatment (Duffy et al 2000; Ronen et al 2001). Both disease 
symptoms and time-consuming treatments may alter quality of life of children with Patient Preference and Adherence 2008:2 122
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JIA by affecting numerous activities of daily living such as 
ﬁ  ne and gross motor activities as well as psychological and 
social functioning. In children with JIA, adherence is often 
measured by asking the parents, who act as proxy reporters 
for their children, since objective adherence is difﬁ  cult to 
measure. This is especially true for some treatments such as 
exercises. Even if self-reported adherence can overestimate 
actual adherence, it can be useful in determining the frequency 
at which patients follow their treatment (Rapoff 2006). More-
over, perceived adherence may be important to measure in 
order to understand the parents’ and children’s motivation to 
change their behavior concerning treatment regimens. This 
is especially important for adolescents, who are at a crucial 
stage for developing self-management behaviours but for 
whom adherence to treatment is often not optimal (Tebbi et al 
1986; Kyngas 1999; McQuaid et al 2003).
According to Feldman and colleagues (2006), adherence 
to treatments in JIA may be associated with better outcomes. 
However, this study looked only at the parents’ perceptions 
of their child’s adherence and HRQOL. Previous results 
obtained from the current study population showed that some 
aspects of quality of life and adherence are not perceived the 
same way by parents and children (Toupin April et al 2006a, 
2006b). Furthermore, the association between adherence and 
HRQOL may differ between parents and children, indicating 
that different aspects of the treatments are seen as associated 
with different outcomes depending on the respondent.
There are a few studies that looked at the link between 
adherence to treatment and quality of life in other popula-
tions. Some of them found that better adherence to treat-
ment was associated with higher HRQOL or better disease 
outcomes (De Smet et al 2006; Oette et al 2006). However, 
one study found that while good adherence to corticosteroids 
resulted in better outcomes for severe asthma, this was not 
the case for mild to moderate asthma, supporting the idea that 
severity of the disease plays an important role in explaining 
outcomes of adherence (Greaves et al 2005). A negative 
association between adherence to treatment and quality of 
life was reported in sickle cell disease (Barakat et al 2005). 
This could be explained by the fact that high adherence to 
treatment can interfere with the patients’ daily activities and 
therefore reduce perceived quality of life.
Other factors may be associated with HRQOL. Severity 
of disease is known to be negatively associated with quality 
of life (Ruperto et al 2004). Also, patients with severe disease 
may be more adherent to medication (Rapoff et al 2005; 
De Smet et al 2006). Disease duration is usually not related 
to quality of life in adult rheumatoid arthritis (Bekkelund 
et al 1995). However, longer disease duration seems to be 
associated with lower adherence to treatment in children 
with JIA (Litt and Cuskey 1981). Age may be associated 
with adherence to treatment, since older children are usually 
less adherent (Tebbi et al 1986; Kyngas 1999; McQuaid et al 
2003). Also, older children may have a lower quality of life 
because of their growing need for autonomy and of difﬁ  culties 
in social functioning, particularly during adolescence. Finally, 
complexity of the regimen may be associated with reduced 
adherence and a lower HRQOL (Greene et al 1982).
The objectives of this study were to examine the associa-
tion between perceived adherence to treatment (medications 
and exercises) and HRQOL in children with arthritis from 
both the children’s and parents’ viewpoints. We also wanted 
to examine these relationships while taking into account 
age, severity and duration of the disease and number of 
prescribed arthritis medications (as a proxy for complexity 
of the regimen).
We hypothesized that HRQOL would be positively asso-
ciated with perceived adherence to treatment.
Methods
Population
The study population consisted of all eligible patients with 
JIA, 9 to 18 years of age, and their parents, who attended the 
JIA clinic at the Montreal Children’s Hospital in Montreal, 
Canada between March 2003 and February 2004. Children 
younger than 9 years old were not included in the study 
because of the attention span and accuracy required to 
respond to the questionnaires. Parents and their children were 
approached to participate if they understood either English or 
French and if the children were currently undergoing treat-
ment with medications or an exercise program for JIA. Par-
ents and children signed informed consent and assent forms, 
respectively. Both parents and children were asked to respond 
to a HRQOL questionnaire and an adherence questionnaire 
on a single occasion. Fathers or mothers accompanying their 
child to the arthritis clinic were asked to respond to the ques-
tionnaires; if both parents were present at the clinic, they could 
either answer the questionnaires in tandem, or could decide 
that one would respond. Family members were included in the 
study only if they were living with the child who had arthritis. 
The study was approved by the Research Ethics Board of the 
Montreal Children’s Hospital.
Measures
Health-related quality of life was measured using the Juvenile 
Arthritis Quality of Life Questionnaire (JAQQ), a validated Patient Preference and Adherence 2008:2 123
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disease speciﬁ  c questionnaire (Duffy et al 1993, 1995, 1997, 
2000). The JAQQ evaluates physical and psychological 
functioning and incorporates speciﬁ  c data from patients to 
measure HRQOL. The JAQQ has 4 domains: gross motor 
function, ﬁ  ne motor function, psychosocial function, general 
symptoms, and a section assessing pain. The questions on the 
four domains are phrased as follows: “How often have you/
your child, over the past two weeks, had difﬁ  culties with the 
following activities as a result of arthritis or its treatment?” 
Items include physical activities such as walking up or down 
a ﬂ  ight of ten stairs, participating in physical education class, 
ﬁ  ne motor activities such as cutting paper with scissors and 
tying shoe laces, psychosocial items such as getting teased 
a lot and feeling frustrated, and symptoms like stiffness 
and joint swelling. Each of the four domains is scored on 
a Likert-type scale from 1 to 7; lower scores indicate less 
difﬁ  culty doing activities. Pain is scored on a 100 mm visual 
analog scale (VAS). The mean score of a domain is calculated 
using the 5 highest scores (which indicate lower quality of 
life) while the total score of the JAQQ is derived by further 
calculating the mean of the four mean scores. The JAQQ 
has good psychometric properties: a good construct valid-
ity when compared with pain scored on a VAS (correlation 
coefﬁ  cient = 0.72) and a responsiveness to change of 0.71 
(Duffy et al 1993, 1995, 1997). This instrument has been 
validated in French and English for children 9 years of age 
and older (Duffy et al 2000).
The Parent Adherence Report Questionnaire (PARQ) 
(De Civita et al 2005), which has been validated in both 
English and French, was used to assess adherence from the 
point of view of the parents. Four questions are repeated for 
each treatment component including medication, exercises 
and splints, and speciﬁ  cally address adherence to treatment, 
difﬁ  culties in following treatment, frequency of negative 
reactions associated with following treatment, and the degree 
of perceived helpfulness of treatment. There is also a ques-
tion assessing who is responsible for making sure that the 
child follows each of the treatments. Questions are scored 
separately on a 100 mm visual analog scale for each type of 
treatment as follows: “For each treatment prescribed to your 
child, please place a single vertical mark on the lines below at 
the level which best describes how often your child follows 
treatment recommendations as prescribed by the healthcare 
provider in the past three months”. We also adapted the 
PARQ so that it could be administered to the children and 
called this questionnaire the Child Adherence Report Ques-
tionnaire (CARQ). The adaptation of the PARQ was minor; 
it involved addressing the questions to the child instead of 
the parent and simplifying some of the wording (eg, how 
hard you found it to follow your treatment” instead of “your 
child’s general level of difﬁ  culty in following treatment”). 
The CARQ used the same visual analog scale as the PARQ 
and can be used with children who are nine years and older 
(McGrath 1986; Varni et al 1987). We pre-tested the CARQ 
in both English and French.
Data collection
While attending a clinic visit, parents completed the quality 
of life and adherence questionnaires (JAQQ and PARQ) in 
the waiting room while children answered equivalent ques-
tionnaires (JAQQ and CARQ) guided by an interviewer in a 
separate room. The same interviewer conducted all the child 
interviews. General demographic information and clinical 
data obtained from the charts included: age, gender, diagnosis 
(type of JIA), date of diagnosis, age at onset, sum of joint 
severity score (measure of disease severity) and number of 
prescribed arthritis medications. Sum of joint severity score 
(SJSS) is the sum of individual joint scores for effusion, 
tenderness and limitation in range of motion. Higher scores 
indicate higher severity (PRCSG 1982). We used the num-
ber of prescribed arthritis medications as a proxy for the 
complexity of the treatment regimen. Data concerning the 
number, frequency and types of prescribed exercises were 
not available. Exercise programs could vary from one child 
to the next because the physical therapist had tailored them 
to the speciﬁ  c needs of each child.
Analysis
Pearson correlation coefﬁ  cients were used to analyze the 
association between perceived adherence to treatment and 
HRQOL. Linear regression models explored the associations, 
taking into account age of the children, severity and duration 
of the disease and number of prescribed arthritis medications. 
Because age, severity and duration did not follow a normal 
distribution, we dichotomized these variables at the median 
score. Age was classiﬁ  ed as 8 to 12 years old and 13 to 18 
years old, duration was classiﬁ  ed as 0 to 5 years and 6 to 16 
years, and severity of the disease measured by the SJSS was 
classiﬁ  ed as 0 to 1 and 2 to 40. SJSS categories indicate the 
quasi absence vs. the presence of joint activity. Interactions 
between some factors (disease severity, disease duration and 
age) and adherence were also tested, since severity, duration 
and age may modify the association between adherence and 
quality of life. A linear regression also explored the associa-
tions between adherence to treatment and pain while taking 
into account the same cofactors (age, severity, duration of Patient Preference and Adherence 2008:2 124
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the disease, and number of prescribed arthritis medications). 
We performed these analyses separately for both parents 
and children.
Results
There were 17 persons (23.6%) who declined to participate 
in this parent-child dyad study. Another ﬁ  ve started to 
complete the questionnaires but did not have time to ﬁ  n-
ish because of their appointment with the rheumatologist, 
leaving a total of 50 pairs who completed the questionnaires 
in their entirety. The children who refused to participate 
in the study were similar to the children included in the 
study with respect to age (12.94 vs. 12.67, p = 0.7), dis-
ease severity (SJSS: 4.00 vs. 4.76, p = 0.7) and number 
of prescribed medications (mean: 1.65 vs. 1.49, p = 0.6). 
Seventy one percent of nonparticipants were girls and 59% 
were French-speaking nonparticipants, which was also 
similar to participants’ characteristics (p = 0.3 and p = 0.4, 
respectively). Mean age of participating children was 12.67 
years (SD = 2.68) and mean disease duration was 6.13 
years (SD = 4.00). Most of the children were girls (81.8%), 
75.5% of the parent respondents were mothers, and 48.1% 
were French-speaking (Toupin April et al 2006a, 2006b). 
Concerning the types of arthritis, 23.6% of children had 
oligoarthritis, 34.5% polyarthritis, 10.9% systemic arthritis, 
14.5% enthesitis-related arthritis, 7.3% psoriatic arthritis, 
and 9.1% had another type of arthritis. A description of the 
demographic and disease-related characteristics of the cohort 
is summarized in Table 1.
Table 2 describes mean perceived treatment adherence, 
HRQOL, and pain from both the children’s and parents’ per-
spectives as determined by our previous work using the same 
study population (Toupin April et al 2006a, 2006b). Paired 
t-tests indicated no signiﬁ  cant differences between parents’ 
and children’s assessments of these constructs. However, 
our previous work indicated that the agreements between 
parents and children for adherence to medications and the ﬁ  ne 
motor function subscore of HRQOL were low (ICC = 0.32, 
95% CI = 0.04, 0.56 and ICC = 0.35, 95% CI = 0.08, 0.57, 
respectively). Moreover, agreement for adherence to exer-
cises between adolescents and their parents was lower than 
for younger children (Toupin April et al 2006b).
In the current study, better perceived adherence to medi-
cations was associated with a better HRQOL according to 
the children (Pearson r = −0.43, (p  0.01). However, this 
association was not signiﬁ  cant according to the parents’ 
point of view (Pearson r = −0.28, p = 0.08). Perceived adher-
ence to exercises was not associated with HRQOL from the 
children’s (Pearson r = −0.08, p = 0.64) or the parents’ points 
of view (Pearson r = −0.17, p = 0.31).
We used multiple linear regression to adjust for age, 
severity, duration of disease and number of prescribed 
arthritis medications (see Table 3). Better perceived adher-
ence to medications remained associated with a better 
HRQOL from the children’s perspective. However, better 
perceived adherence to exercises was associated with a 
better HRQOL from the parents’ perspective. Other factors 
associated with HRQOL were disease severity and number 
of prescribed medications. Higher disease severity was 
strongly associated with a lower HRQOL from both parents’ 
and children’s perspectives while number of prescribed 
medications was negatively associated with HRQOL from 
the children’s point of view. Age and disease duration 
showed no association with HRQOL. Neither the interac-
tion between severity and adherence, that between duration 
and adherence nor that between age and adherence were 
signiﬁ  cantly associated with HRQOL from the parents’ or 
children’s perspectives.
Further analyses showed that perceived adherence to 
medication according to children was associated with three 
of the four domains of the HRQOL (see Table 4). Higher 
adherence to medication was associated with better ﬁ  ne motor 
function, gross motor function and psychosocial function. 
However, adherence to medication was not signiﬁ  cantly 
associated with symptoms. Higher disease severity was 
associated with lower gross motor function while higher 
Table 1 Demographic, disease-related, and treatment-related 
characteristics of the sample of children with juvenile idiopathic 
arthritis (n = 50)
  Mean (SD)  Range  n (%)
Age (years)  12.67 (2.68)  8–18 
Age at onset (years)  6.55 (4.48)  Birth–14 
Disease duration (years)  6.13 (4.00)  0–16 
Active joint count (AJC)  1.07 (1.76)  0–10 
Sum of joint severity   4.76 (7.25)  0–40 
score (SJSS)
Use of medications      43 (82.7)
Use of NSAID      33 (60)
Use of corticosteroids      6 (10.9)
Use of TNFα-inhibitors     7  (12.7)
Use of other DMARDs      33 (60)
Use of subcutaneous drugs      23 (41.8)
Number of prescribed   1.54 (1.06)  0–4
arthritis medications
Side effects      13 (31.7)
Use of exercises      27 (51.9)
Abbreviations: DMARDs, disease-modifying antirheumatic drugs; NSAID, nonste-
roidal anti-inﬂ  ammatory drugs.Patient Preference and Adherence 2008:2 125
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number of prescribed medications was associated with lower 
ﬁ  ne motor function.
Also, according to parents, perceived adherence to exer-
cises was associated with only two of the four domains of 
HRQOL. Adherence to exercises was associated with less 
symptoms and better psychosocial functioning (see Table 5). 
However, adherence to exercises was not associated with 
other domains of HRQOL. Higher disease severity was asso-
ciated with lower gross motor function, lower psychosocial 
functioning and more symptoms while number of prescribed 
medications did not seem to have an impact on HRQOL 
according to parents.
Both adherence to medication and exercises were not 
associated with pain from the children’s points of view 
(β = −0.08, 95% CI = −0.48, 0.32 and β = −0.15, 95% 
CI = −0.39, 0.09, respectively) or from the parents’ points 
of view (β = 0.07, 95% CI = −0.25, 0.39 and β = −0.03, 95% 
CI = −0.27, 0.21, respectively).
Discussion
Our results indicate that parents and children perceive 
treatment adherence to be associated with better HRQOL. 
However, parents and children have different opinions on 
which treatment is associated with improved HRQOL.
Perceived adherence to medications in JIA was associated 
with HRQOL from the child’s perspective. More speciﬁ  cally, 
it was associated with higher ﬁ  ne motor function, gross motor 
function and psychosocial functioning. These are all aspects 
which are important for children and adolescent participation 
in daily activities and peer interactions. This association was 
in accordance with our hypotheses. Perhaps children feel 
that taking their medications really improves their quality 
of life. Also, children who have a better HRQOL may be 
more motivated to take their medications, especially if they 
believe it improved their health. This is consistent with 
previous ﬁ  ndings which showed that children with JIA per-
ceived medications as being helpful and are more adherent 
Table 2 Mean perceived adherence and health-related quality of life (HRQOL) of children with juvenile idiopathic arthritis according 
to parents and children (n = 50)
  Mean (SD)   Mean (SD)   P* value for the comparison
  According to children  According to parents  between parents and children
Treatment adherence1:    
  To medications  84.45 (17.63)  83.07 (21.12)  0.59
  To exercises  61.60 (28.85)  54.88 (31.15)  0.24
HRQOL2:    
Gross motor  2.53 (1.40)  2.80 (1.93)  0.14
Fine motor  1.52 (0.83)  1.61 (0.84)  0.54
Psychosocial  2.16 (1.08)  2.22 (1.20)  0.82
Symptoms  2.41 (1.06)  2.44 (1.20)  0.78
Total score  2.15 (0.86)  2.27 (0.93)  0.27
Pain3: 20.70  (21.28)  17.99  (22.10)  0.27
Notes: 1On a visual analog scale from 0 to 100, 100 being a better adherence; 2On a scale from 1 to 7, 7 being a worse HRQOL; 3On a visual analog scale from 0 to 100, 
100 being worse pain; *Paired t-test.
Table 3 Regression models of factors associated with health-related quality of life (total score)
Factors  β (95% CI) (according to children)  β (95% CI) (according to parents)
Adherence to medications  −0.02 (−0.04, -0.01)*  −0.006 (−0.02, 0.005)
Disease severity (SJSS)  0.53 (0.04, 1.02)*  1.04 (0.54, 1.53)*
Disease duration  −0.01 (−0.44, 0.46)  0.13 (−0.36, 0.62)
Age 0.36  (−0.07, 0.79)  0.32 (−0.14, 0.79)
Number of prescribed medications  0.31 (0.07, 0.55)*  −0.05 (−0.31, 0.21)
R2 0.48  0.49
Adherence to exercises  −0.002 (−0.01, 0.01)  −0.008 (−0.02, 0.000)*
Disease severity (SJSS)  0.73 (0.19, 1.27)*  1.25 (0.74, 1.76)*
Disease duration  −0.04 (−0.55, 0.46)  0.07 (−0.39, 0.53)
Age 0.28  (−0.23, 0.79)  0.04 (−0.46, 0.55)
Number of prescribed medications  0.23 (0.004, 0.46)*  0.02 (−0.21, 0.25)
R2 0.35  0.53
Notes: *p  0.05.Patient Preference and Adherence 2008:2 126
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to medications than exercises (Toupin April et al 2006b). On 
the other hand, exercises are time and energy consuming, 
and may interfere with social aspects of their life much more 
than medication. This is especially true for adolescents, for 
whom social activities are often given a larger priority and 
who experience many difﬁ  culties with respect to HRQOL 
(Shaw et al 2006). Adolescents are also more responsible for 
their own treatment than younger children, which is indicated 
by the difference in percentage of children responsible for 
following their treatments between adolescents and younger 
children in our sample (34.8% and 28% for medications and 
73.9% and 45% for exercises, respectively). Children may 
have difﬁ  culty performing exercises properly and there-
fore fail to feel the beneﬁ  ts on HRQOL. These difﬁ  culties 
may also be exacerbated by the fact that parents are less 
responsible (either partially or fully) for ensuring adherence 
to exercises than medications (44.2% vs. 86.4%) (Toupin 
April et al 2006b).
Perceived adherence to exercises was associated with 
HRQOL total score according to parents, which corrobo-
rates our hypotheses. When looking closer at the domains of 
HRQOL, it was associated with fewer symptoms and better 
psychosocial functioning. This may indicate that good adher-
ence to exercises reduces the manifestation of the disease and 
improves the psychosocial functioning of their child. This 
could explain why, in a previous study with the same study 
population, we found that 80% of parents perceived exercises 
as being helpful (Toupin April et al 2006b). Another plau-
sible explanation is that children with fewer symptoms and 
better psychosocial function have an easier time doing their 
exercises and tend to adhere more to this aspect of treatment 
as compared with those with more symptoms and psychoso-
cial problems. Parents may favor exercises because they are 
worried about possible side effects of medications.
Discrepancies between parents and children may reveal 
different views of treatment helpfulness, adherence and its 
Table 4 Regression models of factors associated with health-related quality of life domains from the children’s point of view
Adherence to treatments  Fine motor function  Gross motor function  Psychosocial function  Symptoms
   β (95%CI)  β (95%CI)  β (95%CI)  β (95%CI)
Adherence to medications  −0.01 (−0.03, -0.001)*  −0.03 (−0.05, −0.01)*  −0.03 (−0.05, −0.01)*  −0.02 (−0.03, 0.003)
Disease severity (SJSS)  0.30 (−0.24, 0.83)  0.96 (0.20, 1.73)*  0.28 (−0.42, 0.97)  0.59 (−0.09, 1.28)
Disease duration  0.03 (−0.52, 0.46)  −0.06 (−0.76, 0.65)  −0.07 (−0.70, 0.57)  0.18 (−0.45, 0.80)
Age  −0.06 (−0.41, 0.54)  0.64 (−0.04, 1.31)  0.31 (−0.30, 0.92)  0.42 (−0.18, 1.02)
Number of prescribed medications  0.48 (0.22, 0.74)*  0.30 (−0.07, 0.68)  0.18 (−0.16, 0.52)  0.26 (−0.07, 0.59)
R2 0.38  0.46  0.29  0.31
Adherence to exercises 0.003  (−0.01, 0.01)  0.002 (−0.01, 0.02)  −0.01 (−0.02, 0.01)  −0.004 (−0.02, 0.01)
Disease severity (SJSS)  0.51 (−0.08, 1.11)  1.24 (0.44, 2.05)*  0.31 (−0.50, 1.11)  0.89 (0.17, 1.61)*
Disease duration  −0.16 (−0.71, 0.40)  −0.22 (−0.98, 0.53)  0.20 (−0.55, 0.95)  −0.03 (−0.70, 0.65)
Age 0.04  (−0.52, 0.59)  0.65 (−0.11, 1.40)  0.09 (−0.67, 0.84)  0.37 (−0.30, 1.04)
Number of prescribed medications  0.39 (0.14, 0.64)*  0.15 (−0.19, 0.48)  0.19 (−0.15, 0.53)  0.18 (−0.13, 0.49)
R2 0.31  0.36  0.12  0.30
Notes: *p  0.05.
Table 5 Regression models of factors associated with health-related quality of life domains from the parents’ point of view
Adherence to treatments  Fine motor function   Gross motor function   Psychosocial function   Symptoms 
  β (95%CI)  β (95%CI)  β (95%CI)  β (95%CI)
Adherence to medications  −0.001 (−0.01, 0.01)  −0.02 (−0.04, 0.01)  −0.001 (−0.02, 0.02)  −0.01 (−0.02, 0.01)
Disease severity (SJSS)  0.26 (−0.32, 0.84)  1.93 (0.83, 3.03)*  0.64 (-0.08, 1.35)  1.32 (0.55, 2.09)*
Disease duration  0.28 (−0.29, 0.85)  0.06 (−1.03, 1.15)  0.20 (−0.50, 0.90)  −0.03 (−0.80, 0.73)
Age 0.38  (−0.16, 0.93)  0.68 (−0.35, 1.72)  −0.09(−0.76, 0.58)  0.31 (−0.42, 1.03)
Number of prescribed medications  0.14 (−0.16, 0.44)  v0.19 (−0.77, 0.38)  −0.20 (−0.57, 0.18)  0.04 (−0.36, 0.45)
R2 0.16  0.43  0.15  0.34
Adherence to exercises 0.01  (−0.01, 0.02)  −0.01 (−0.03, 0.01)  −0.01 (−0.03, −0.002)*  −0.01 (−0.03, 0.001)*
Disease severity (SJSS)  0.14 (−0.50, 0.77)  2.21 (0.96, 3.45)*  0.99 (0.25, 1.74)*  1.66 (0.91, 2.42)*
Disease duration  0.30 (−0.27, 0.88)  0.18 (−0.95, 1.30)  0.10 (−0.57, 0.77)  −0.30 (−0.98, 0.38)
Age 0.55  (−0.08, 1.18)  0.29 (−0.94, 1.52)  −0.51 (−1.24, 0.23)  −0.16 (−0.91, 0.58)
Number of prescribed medications  0.14 (−0.14, 0.43)  −0.13 (−0.68, 0.42)  −0.04 (−0.37, 0.29)  0.11 (−0.22, 0.44)
R2 0.20  0.39  0.27  0.44
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importance in the lives of parents and children, which is 
consistent with previous ﬁ  ndings (Toupin April et al 2006b). 
It may be problematic, especially for adolescents since they 
are at risk of nonadherence and are at a crucial stage for 
developing self-management behaviors.
Disease severity was associated with HRQOL. Those 
with higher disease severity had a lower perceived HRQOL, 
which has been shown by others (Ruperto et al 2004). 
Although the main effect was signiﬁ  cant, there was no 
interaction between severity and adherence which is not 
consistent with the ﬁ  ndings of Greaves and colleagues (2005) 
in asthma. However, most of the children in our study did not 
have severe disease. Also, disease duration was not associated 
with perceived HRQOL which is consistent with the ﬁ  ndings 
of Bekkelund and colleagues (1995). However, age was not 
signiﬁ  cantly associated with perceived HRQOL, which is not 
perfectly in tune with Shaw and colleague’s (2006) ﬁ  nding 
that adolescents experience many difﬁ  culties with respect 
to HRQOL. The interaction between age and adherence to 
treatment was also nonsigniﬁ  cant, which may reveal that 
adolescents and younger children have approximately the 
same views of the association between treatment adherence 
and their HRQOL.
Following a more complex treatment regimen (having a 
higher number of prescribed arthritis medications) was asso-
ciated with lower HRQOL according to children. This may 
reﬂ  ect that children who were prescribed more medications 
have a more severe disease and a lower HRQOL. However, 
the regression model controlled for disease severity. Perhaps 
following a more complex medical regimen may have a 
negative impact on HRQOL because of the time involved 
in following treatments or possible resultant side effects. 
Moreover, higher number of prescribed medications was 
associated with lower ﬁ  ne motor function, which could be 
explained by the fact that children who take more medica-
tion may have more severe disease and take subcutaneous 
medications which involve a high burden of care. Children 
may be reluctant to undergo an additional time and energy 
consuming treatment such as exercises, which may result in 
stiffness of the upper extremities and decreased ﬁ  ne motor 
function. Those who take more medication may also have 
more polyarticular involvement (often involving joints in the 
ﬁ  ngers and hands) leading to lower ﬁ  ne motor function.
Perceived adherence to exercises in JIA was not asso-
ciated with HRQOL from the children’s perspective and 
perceived adherence to medications was not associated with 
HRQOL according to the parents. Although these results 
did not support our initial hypotheses, they were similar to 
those of Hays and colleagues (1994). There may be factors 
inﬂ  uencing adherence that contribute to the complexity of the 
relationship between adherence and HRQOL. For example, 
disease severity and perceived effectiveness of the particu-
lar treatment appear to inﬂ  uence adherence (De Smet et al 
2006; Feldman et al 2007). The next step would be to build 
a model that examines factors predicting adherence in order 
to better understand this important concept and its associa-
tion with HRQOL.
Study limitations
Parents who accepted to participate in this study may be dif-
ferent than nonparticipants, leading to a possible selection 
bias. Participants may be more motivated, want to learn more 
about their child’s state and be more communicative. Their 
children may be more adherent to treatment than those who 
refused to participate. Also, these children may have a better 
HRQOL since their parents want to share their experiences 
with the researchers. These characteristics of the respond-
ers could reinforce our hypothesis of a positive association 
between adherence to treatment and HRQOL. Nevertheless, 
we found different results for parents and children regarding 
the association between adherence and HRQOL. Social desir-
ability bias may have occurred because children answered the 
questionnaires with an interviewer, possibly overestimating 
their adherence and HRQOL.
In the linear regression models, age, severity, duration 
of disease, and number of prescribed arthritis medications 
were included but other factors may have been important to 
consider, eg, comorbidities and socioeconomic status. Also, 
the number of prescribed medications is an imperfect proxy 
for the complexity of the regimen given that children often 
have to do exercises simultaneously. Unfortunately, we did 
not have information on the exact exercise regimen. Treat-
ment adherence was assessed in a subjective fashion; we 
wished to evaluate the perceived impact of the treatments 
and therefore understand the motivations of both parents and 
children in following treatment regimens.
Finally, we cannot conclude that there is a causal asso-
ciation between perceived adherence and HRQOL since the 
study design was cross-sectional. It is possible that higher 
perceived adherence has a positive effect on HRQOL or 
that better HRQOL has an impact on perceived adherence. 
Longitudinal studies could help elucidate this relationship.
Conclusion
Perceived adherence to treatment was associated with certain 
aspects of HRQOL which may indicate that medications Patient Preference and Adherence 2008:2 128
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and exercises decrease the effects of disease and result 
in improved HRQOL. However, other variables such as 
complexity of the medical regimen seem to be negatively 
associated with outcomes according to children’s point of 
view. Our results indicate that parents and children perceive 
adherence to treatment to be associated with different out-
comes. Understanding perceptions and motivations of both 
informants regarding treatment is crucial since children learn 
how to comply with their treatment regimen with the help 
from their parents. More communication between parents, 
children and their health care providers may lead to a better 
understanding of each other’s goals in treatment, better treat-
ment adherence and ultimately better outcomes.
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